Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-07-01T11:43:52.643Z Has data issue: false hasContentIssue false
  • English
  • Français

Estimating the cost of inappropriate antibiotic prophylaxis prior to dental procedures

Published online by Cambridge University Press:  10 July 2023

Cynthia L. Gong Open the ORCID record for Cynthia L. Gong [Opens in a new window] ,
Anh Duong  and
Kenneth M. Zangwill
Cynthia L. Gong*
Affiliation:
Division of Neonatology, Fetal & Neonatal Institute, Children’s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
Anh Duong
Affiliation:
Alfred E. Mann School of Pharmacy, University of Southern California, Los Angeles, California
Kenneth M. Zangwill
Affiliation:
Division of Pediatric Infectious Diseases, Department of Infection Prevention and Control, and The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California
*
Corresponding author: Cynthia L. Gong; Email: gongc@usc.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Inappropriate dental antibiotic prescriptions to prevent infective endocarditis in the United States results in ∼$31 million in excess costs to the healthcare system and patients. This includes out-of-pocket costs ($20.5 million), drug costs ($2.69 million) and adverse event costs (eg, Clostridioides difficile and hypersensitivity) of $5.82 million (amoxicillin), $1.99 million (clindamycin), and $380,849 (cephalexin).

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 11 , November 2023 , pp. 1850 - 1853
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wilson, WR, Gewitz, M, Lockhart, PB, et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation 2021;143:E963–E978.CrossRefGoogle ScholarPubMed
Suda, KJ, Calip, GS, Zhou, J, et al. Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015. JAMA Netw Open 2019;2:e193909.CrossRefGoogle ScholarPubMed
Suda, KJ, Fitzpatrick, MA, Gibson, G, et al. Antibiotic prophylaxis prescriptions prior to dental visits in the Veterans’ Health Administration (VHA), 2015–2019. Infect Control Hosp Epidemiol 2022;43:1565–1574.CrossRefGoogle ScholarPubMed
Hubbard, CC, Evans, CT, Calip, GS, Zhou, J, Rowan, SA, Suda, KJ. Appropriateness of antibiotic prophylaxis before dental procedures, 2016–2018. Am J Prev Med 2022;62:943–948.CrossRefGoogle ScholarPubMed
Gross, AE, Suda, KJ, Zhou, J, et al. Serious antibiotic-related adverse effects following unnecessary dental prophylaxis in the United States. Infect Control Hosp Epidemiol 2021;42:110–112.CrossRefGoogle ScholarPubMed
Wilson, GM, Evans, CT, Fitzpatrick, MA, et al. Clostridioides difficile infection following dental antibiotic prescriptions in a cohort of US veterans. Infect Control Hosp Epidemiol 2023;44:494–496.CrossRefGoogle Scholar
Thornhill, MH, Dayer, MJ, Prendergast, B, Baddour, LM, Jones, S, Lockhart, PB. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother 2015;70:2382–2388.CrossRefGoogle ScholarPubMed
Ofori, E, Ramai, D, Dhawan, M, Mustafa, F, Gasperino, J, Reddy, M. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect 2018;99:436–442.CrossRefGoogle ScholarPubMed
Liang, EH, Chen, LH, Macy, E. Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: a retrospective population-based study. J Allergy Clin Immunol Pract 2020;8:1302–1313.CrossRefGoogle ScholarPubMed
Macy, E, Contreras, R. Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis. J Allergy Clin Immunol 2015;135:745–752.CrossRefGoogle ScholarPubMed
Duval, X, Alla, F, Hoen, B, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 2006;42:e102–e107.CrossRefGoogle ScholarPubMed
Quan, TP, Muller-Pebody, B, Fawcett, N, et al. Investigation of the impact of the NICE guidelines regarding antibiotic prophylaxis during invasive dental procedures on the incidence of infective endocarditis in England: an electronic health records study. BMC Med 2020;18:84.CrossRefGoogle ScholarPubMed
Supplementary material: File

Gong et al. supplementary material

Gong et al. supplementary material

Download Gong et al. supplementary material(File)
File 26.7 KB